Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Universal Health Coverage Day 2018

 
Universal Health Coverage Day 2018
Unite for Universal Health Coverage: Now is the Time for Collective Action

http://www.emro.who.int/media/news/universal-health-coverage-day-2018.html

12 December 2018, Cairo ‒ Universal Health Coverage (UHC) Day, commemorated each 12 December, is the anniversary of the first unanimous United Nations resolution calling for countries to provide affordable, quality health care to every person, everywhere.

“UHC is a simple idea: that everyone should be able to access the health services they need, without suffering financial hardship. Globally, we have a lot of work to do to realise that dream,” said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO).

“At least half of the world's population cannot access essential services like vaccination, essential medicines, or the ability to see a health worker. And every year, nearly 100 million people are pushed into extreme poverty due to out-of-pocket health spending.”

In the WHO Eastern Mediterranean Region, around 40% of health expenditure comes directly from people’s pockets, and most people cannot afford it. People with low incomes and without social protection are the hardest hit. As a result, an estimated 7.5 million people are pushed into poverty every year in the Region due to spending on health.

UHC has a special relevance to people living in countries with acute and prolonged emergency situations, and therefore for the Region, given that half of the world’s internally displaced populations are living in countries of the Region and more than 60% of the world’s refugees and migrants originate from the Region.

Vision 2023, developed by Dr Ahmed Al-Mandhari, WHO Regional Director for the Eastern Mediterranean, to guide the Organization’s work, acknowledges the socioeconomic diversity, opportunities and challenges facing the Region and calls for solidarity and action to promote “Health for All by All”. In line with WHO’s Thirteenth General Programme of Work 2019–2023, Vision 2023 has identified expanding UHC as a top strategic priority for the Region, and focuses on implementing the recommendations of the Salalah Declaration on UHC of September 2018 to ensure that at least 100 million more people benefit from UHC by 2023.

“Vision 2023 is a renewed call to aspire to the goal of Health for All, but it also stresses that Health for All can only be achieved by All. To move towards UHC, we need to engage everyone – governments, parliaments, academic and professional institutions, nongovernmental organizations, our sister United Nations agencies, communities, civil society and individuals – as proactive agents for change,” said Dr Al-Mandhari.

“I am glad that the theme for UHC Day 2018 is in harmony with our vision of Health for All by All. We shall all unite for UHC. Now is the time for collective action.”

Ministers of health and heads of delegations from the countries of the Region have recently collectively signed the UHC2030 Global Compact, making the Region the first among WHO’s six regions to do so. The signing of the UHC2030 Global Compact demonstrates a high level of commitment to take action and make progress towards UHC by the countries of the Region. Furthermore, WHO’s Regional Committee for the Eastern Mediterranean in its 65th Session this year endorsed a resolution urging Member States to formulate a national vision for UHC and a roadmap towards its realization, taking into account country-specific health system challenges, the economic situation and people’s preferences.

The essence of UHC is the provision of an essential package of health services to the whole population and ensuring that those who cannot pay for health care are financially protected through prepayment schemes. Every country can make progress towards UHC, even low-income countries and those affected by emergencies. 

“Providing a basic package of health services for all, and then employing progressive universalism by building on this package as more resources become available, is the way to go about it”, said Dr Zafar Mirza, Director, Health System Development at the WHO Regional Office for the Eastern Mediterranean.
    ...
    184
    ...
ATC Name B/G Ingredients Dosage Form Price
D06AX01 FUCIDIN B Fusidic acid - 20mg/g 2% Cream 259,362 L.L
G03DA04 PROGESTOGEL B Progesterone - 1% 1% Gel 542,912 L.L
L04AD02 ADVAGRAF B Tacrolimus monohydrate - 3mg 3mg Capsule, prolonged release 68,645,618 L.L
N02BE51 PANADOL SINUS B Paracetamol - 500mg, Pseudoephedrine HCl - 30mg Caplet 228,453 L.L
N05AH03 ZYPREXA B Olanzapine - 10mg 10mg Tablet 1,468,820 L.L
S01EA05 ALPHAGAN P B Brimonidine tartrate - 1.5mg/ml 0.15% Drops solution 999,819 L.L
D06AX01 FUCIDIN CREAM B Fusidic acid - 2% 2% Cream 491,846 L.L
G03DA04 PROGESTOGEL B Progesterone - 1% 1% Gel 542,912 L.L
J01DH02 MERONEM B Meropenem (trihydrate) - 1g 1g Injectable powder for solution 10,398,061 L.L
J05AB01 ZOVIRAX B Aciclovir - 200mg/5ml 200mg/5ml Suspension 487,815 L.L
L04AD02 ADVAGRAF B Tacrolimus monohydrate - 1mg 1mg Capsule, prolonged release 25,729,044 L.L
N05AH03 ZYPREXA B Olanzapine - 10mg 10mg Tablet 1,468,820 L.L
C09DX03 VOCADO HCT B Olmesartan medoxomil - 40mg, Amlodipine - 5mg, Hydrochlorothiazide - 25mg Tablet, film coated 1,523,917 L.L
D06AX01 FUCIDIN CREAM B Fusidic acid - 2% 2% Cream 345,368 L.L
L04AD02 ADVAGRAF B Tacrolimus monohydrate - 5mg 5mg Capsule, prolonged release 85,485,667 L.L
N02BE51 PANADOL COLD & FLU DAY B Paracetamol - 500mg, Caffeine - 25mg, Phenylephrine HCl - 5mg Caplet 284,895 L.L
L01FX29 TALVEY B Talquetamab - 2mg/ml 3mg/1.5ml Injectable solution 45,594,403 L.L
L04AD02 ADVAGRAF B Tacrolimus monohydrate - 0.5mg 0.5mg Capsule, prolonged release 13,297,758 L.L
M03BA03 LUMIRELAX B Methocarbamol - 500mg 500mg Tablet 667,890 L.L
N02BE51 PANADOL COLD & FLU ALL IN ONE B Paracetamol - 250mg, Guaifenesin - 100mg, Phenylephrine HCl - 5mg Tablet, film coated 342,680 L.L
L01XK01 LYNPARZA B Olaparib - 150mg 150mg Tablet, film coated L.L
A10BD08 GALVUS MET B Metformin HCl - 1,000mg, Vildagliptin - 50mg Tablet, film coated 1,816,875 L.L
C09DX03 VOCADO HCT B Olmesartan medoxomil - 40mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 1,523,917 L.L
L01FX29 TALVEY B Talquetamab - 40mg/ml 40mg/ml Injectable solution 555,916,745 L.L
L04AE04 PONVORY B Ponesimod - 20mg 20mg Tablet, film coated 80,346,773 L.L
N02BE51 SOLPADEINE B Paracetamol - 500mg, Caffeine - 30mg, Codeine - 8mg Tablet 319,835 L.L
L02AE04 DECAPEPTYL SR B Triptorelin (pamoate) - 3mg 3mg Injectable powder for suspension+diluent L.L
L04AE04 PONVORY B Ponesimod - 2x2mg, 2x3mg, 2x4mg, 1x5mg, 1x6mg, 1x7mg, 1x8mg, 1x9mg, 3x10mg Tablet, film coated 41,177,275 L.L
N02BE51 SOLPADEINE SOLUBLE B Paracetamol - 500mg, Caffeine - 30mg, Codeine - 8mg Tablet, effervescent 326,554 L.L
H01CB03 SOMATULINE AUTOGEL B Lanreotide (acetate) - 120mg 120mg Injectable solution L.L
    ...
    184
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025